Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;39(6):1215-1232.
doi: 10.1007/s11095-022-03256-4. Epub 2022 Apr 19.

Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design

Affiliations

Development of a Spray-Dried Formulation of Peptide-DNA Nanoparticles into a Dry Powder for Pulmonary Delivery Using Factorial Design

Miftakul Munir et al. Pharm Res. 2022 Jun.

Abstract

Background: Gene therapy via pulmonary delivery holds the potential to treat various lung pathologies. To date, spray drying has been the most promising method to produce inhalable powders. The present study determined the parameters required to spray dry nanoparticles (NPs) that contain the delivery peptide, termed RALA (N-WEARLARALARALARHLARALARALRACEA-C), complexed with plasmid DNA into a dry powder form designed for inhalation.

Methods: The spray drying process was optimised using full factorial design with 19 randomly ordered experiments based on the combination of four parameters and three centre points per block. Specifically, mannitol concentration, inlet temperature, spray rate, and spray frequency were varied to observe their effects on process yield, moisture content, a median of particle size distribution, Z-average, zeta potential, encapsulation efficiency of DNA NPs, and DNA recovery. The impact of mannitol concentration was also examined on the spray-dried NPs and evaluated via biological functionality in vitro.

Results: The results demonstrated that mannitol concentration was the strongest variable impacting all responses apart from encapsulation efficiency. All measured responses demonstrated a strong dependency on the experimental variables. Furthermore, spray drying with the optimal variables in combination with a low mannitol concentration (1% and 3%, w/v) produced functional RALA/pDNA NPs.

Conclusion: The optimal parameters have been determined to spray dry RALA/pDNA NPs into an dry powder with excellent biological functionality, which have the potential to be used for gene therapy applications via pulmonary delivery.

Keywords: cell-penetrating peptide; dry powder formulation; gene delivery; pulmonary delivery; spray drying.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Fig. 1
Fig. 1
One Factor Plot Representing the Influence of (A) Mannitol Concentration on Process Yield, (B) Mannitol Concentration on DNA Recovery
Fig. 2
Fig. 2
Contour Plots Presenting a Variation of (A) Median of Particle size Distribution Measured by Laser Light Diffraction Analyzer in Response to Spray Inlet Temperature, Mannitol Concentration and Spray Frequency; (B) Z-average in Response to Inlet Temperature, Mannitol Concentration, and Spray Rate; (C) Zeta Potential in Response to Inlet Temperature, Mannitol Concentration, and Spray Rate
Fig. 3
Fig. 3
3D Plot Representing the Effect of the Mannitol Concentration and Inlet Temperature on Relative Moisture Content
Fig. 4
Fig. 4
Micrographs of Spray-Dried RALA/pEGFP-N1 NPs as a Function of Mannitol Concentration. Spray-Dried RALA/pEGFP-N1 NPs were Sprinkled onto Sticky Carbon Tape Mounted on SEM Stubs and were Observed using SEM at Magnifications of 1000 × and 4000x
Fig. 5
Fig. 5
DSC Thermogram of Spray-Dried RALA/pEGFP-N1 NPs. Spray-Dried RALA/pEGFP-N1 NPs were Sealed into a Hermetic Aluminium Pan, then Analysed using DSC Q50 with a Heat Rate of 5ºC/min from 25 to 200ºC. The Thermal Analysis Data were Analysed using Universal Analysis
Fig. 6
Fig. 6
Overlay and fluorescence Image of in vitro Transfection Efficiency of Spray-Dried RALA/pEGFP-N1 NPs at Different Mannitol Concentrations in Opti-MEM Media Assessed in A549 cells. Spray-dried RALA/pEGFP-N1 complexes were reconstituted with 50 µL of DNase/RNase-free water and incubated for 3 h at room temperature prior to A549 cells transfection (density of 104 cells per well) for 4–6 h in Opti-MEM media. Subsequently, cells were observed under an optical microscope after transfection. Experiments were performed as three independent replicates, and a representative image is shown for each cryoprotectant
Fig. 7
Fig. 7
A In-vitro Transfection of Spray-Dried RALA/pEGFP-N1 complexes at different mannitol concentrations. Cells were trypsinised 48 h and transfection efficiency was measured by flow cytometry. B A549 cells viability after 48 h transfection with spray-dried RALA/pEGFP-N1 NPs in Opti-MEM. Spray-dried RALA/pEGFP-N1 complexes were reconstituted with 50 µL of DNase/RNase-free water and incubated for 3 h at room temperature prior to A549 cells transfection (density of 1 × 104 cells per well) for 4–6 h in Opti-MEM media. 48 h post-transfection, cells were incubated with 10% Alamar blue reagent for 2–3 h and absorbance was measured in a plate reader. Results displayed as mean ± SEM, n = 3. (** p < 0.01, **** p < 0.0001; ANOVA)

Similar articles

Cited by

References

    1. Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR. Gene therapy clinical trials worldwide to 2017: An update. J Gene Med. 2018;20(5):e3015. - PubMed
    1. Lee HY, Mohammed KA, Nasreen N. Nanoparticle-based targeted gene therapy for lung cancer. Am J Cancer Res. 2016;6:1118–1134. - PMC - PubMed
    1. Bennett R, Yakkundi A, McKeen HD, McClements L, McKeogh TJ, McCrudden CM, et al. RALA-mediated delivery of FKBPL nucleic acid therapeutics. Nanomedicine. 2015;10:2989–3001. doi: 10.2217/nnm.15.115. - DOI - PMC - PubMed
    1. Mulholland EJ, Ali A, Robson T, Dunne NJ, McCarthy HO. Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: An innovative angiogenic therapy for wound repair. J Control Release [Internet]. Elsevier. 2019;316:53–65. doi: 10.1016/j.jconrel.2019.10.050. - DOI - PubMed
    1. Mccarthy HO, McCaffrey J, Mccrudden CM, Zholobenko A, Ali AA, McBride JW, et al. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery. J Control Release. Elsevier B.V. 2014;189:141–149. doi: 10.1016/j.jconrel.2014.06.048. - DOI - PubMed

LinkOut - more resources